Home / Retatrutide calculator
Retatrutide reconstitution calculator
Retatrutide is still in phase 3 and has no approved product, so any vial sold today is an unapproved drug with unchecked contents. The math below only converts a dose into syringe units.
Retatrutide units chart
Units on a U-100 syringe with 2 mL of bacteriostatic water. Dose levels used in the phase 3 TRIUMPH trials. Retatrutide is not approved.
| Dose | 10 mg vial 5 mg/mL | 20 mg vial 10 mg/mL | 30 mg vial 15 mg/mL | 60 mg vial 30 mg/mL |
|---|---|---|---|---|
| 2 mg | 40 u | 20 u | 13.3 u | 6.7 u |
| 4 mg | 80 u | 40 u | 26.7 u | 13.3 u |
| 9 mg | 180 u (>1 mL) | 90 u | 60 u | 30 u |
| 12 mg | – | 120 u (>1 mL) | 80 u | 40 u |
Vial sizes are examples for the math. Read the exact mg on your own vial.
Dose schedule
See the full Retatrutide dosage chart and regulatory status, with sources.
Units are not mg. "10 units" on a syringe is 0.1 mL. How many mg that holds depends on how the vial was mixed. If a prescription is written in units, confirm the concentration it assumes.
Questions
- How many units is 2 mg of retatrutide?
- It depends on the vial and water. With a 10 mg vial and 2 mL of water (5 mg/mL), 2 mg is 40 units on a U-100 syringe. Use the calculator for your own vial.
- How much bacteriostatic water should I add to a 20 mg retatrutide vial?
- Any amount works mathematically; it only changes the concentration. With 2 mL, 4 mg is 40 units. Follow the pharmacy or prescriber's mixing instructions if you have them, and see the BAC water calculator to land a dose on a round number of units.
- Is retatrutide FDA-approved?
- Investigational and not approved. Eli Lilly is running the phase 3 TRIUMPH program and plans to file with the FDA in early 2027. It is not on any compounding list, so it cannot be legally compounded, and FDA warning letters in 2026 named retatrutide sold as a "research" product.
Sources
- Jastreboff et al. Triple-hormone-receptor agonist retatrutide for obesity: a phase 2 trial. NEJM 2023
- AJMC: Retatrutide achieves up to 30.3% average weight loss in phase 3 TRIUMPH-1
- Healio: Retatrutide confers up to 28.7% weight loss in knee osteoarthritis (TRIUMPH-4)
- FDA: Dosing errors associated with compounded semaglutide
- FDA 510(k) K212499: BD insulin syringes for U-100 insulin
Last checked 2026-11-16. How we pick and check sources: methodology.